UK markets closed

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
39.04-0.28 (-0.71%)
As of 03:42PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-517,180
-408,168
-570,279
-213,796
-118,668
Depreciation & amortisation
6,709
6,912
1,386
1,393
72
Stock-based compensation
59,899
28,787
193,556
65,639
29,500
Change in working capital
61,045
24,613
-28,604
1,664
8,977
Accounts payable
20,187
4,874
5,928
1,025
222
Other working capital
-359,477
-334,773
-338,763
-146,778
-78,654
Other non-cash items
32,803
16,131
96,252
4,521
-
Net cash provided by operating activities
-356,724
-331,725
-297,689
-145,840
-75,957
Cash flows from investing activities
Investments in property, plant and equipment
-2,753
-3,048
-41,074
-938
-2,697
Purchases of investments
-211,383
-194,121
-263,716
0
0
Sales/maturities of investments
378,665
326,999
0
0
-
Net cash used for investing activities
164,920
129,830
-304,790
944
-2,697
Cash flows from financing activities
Common stock issued
-
243,225
283,804
0
0
Other financing activities
-56,433
-31,317
483,793
138,447
152,242
Net cash used provided by (used for) financing activities
188,663
211,908
767,597
138,447
152,242
Net change in cash
-3,659
9,516
165,547
-6,449
73,588
Cash at beginning of period
190,590
242,604
77,057
83,506
9,918
Cash at end of period
187,449
252,120
242,604
77,057
83,506
Free cash flow
Operating cash flow
-356,724
-331,725
-297,689
-145,840
-75,957
Capital expenditure
-2,753
-3,048
-41,074
-938
-2,697
Free cash flow
-359,477
-334,773
-338,763
-146,778
-78,654